Sub Banner Image

Italy’s Chiesi Raises Annual Guidance on Drug Sales Growth

Markets

Alberto Brambilla, Tiago Ramos Alfaro

·

September 16, 2025

·

Bloomberg

Italian pharmaceutical company Chiesi Group said it expects to beat its financial guidance for the year, boosted by strong sales at its rare diseases unit.

More from

Bloomberg

More

Markets

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.